Cardiovascular Diseases Clinical Trial
To elucidate the role of biobehavioral factors in the etiology, pathogenesis and course of coronary heart disease (CHD) and to use this knowledge to devise more effective prevention, treatment and rehabilitation approaches.
BACKGROUND:
The integrating theme of the study is that hostility affects both behaviors and biologic
functions in ways that increase the risks of developing coronary atherosclerosis or
suffering an acute CHD event. Disciplines involved include psychology, internal medicine,
cardiology, psychiatry, pharmacology, biostatistics, epidemiology, and molecular biology.
DESIGN NARRATIVE:
There were five subprojects in the original program project grant. Subproject 1 examined the
social, behavioral and biologic concommitants of both natural and experimental interpersonal
conflicts as a function of multimodal hostility assessments. Subproject 2 examined the role
of hostility and social support in survival among CHD patients and attempted to identify the
behavioral mediators of survival effects. Subproject 4 evaluated the effects of hostility,
both alone and jointly with risk factors and social factors, on CHD incidence in over 5,000
participants in the University of North Carolina Alumni Heart Study. Subproject 5 evaluated
the effects of age, smoking, lipids, and adrenergic receptors on physiologic reactivity of
hostile and nonhostile men to anger induced by interpersonal challenges in the lab as well
as the events of daily life. Subproject 7 extended the evaluation of anger-associated
biologic reactivity in hostile and nonhostile persons by studying biobehavioral responses of
200 women employed in a real world high stress work situation; it also evaluated the impact
of a stress management intervention designed to reduce anger on biobehavioral reactivity in
these same employees.
The study was renewed in fiscal year (FY) 1997 to expand the primary focus on hostility to
include a set of psychosocial, behavioral, and biological characteristics that increased
coronary heart disease risk and appeared to cluster in certain individuals and groups,
especially those low in socioeconomic status (SES). Subproject 1 examined in approximately
360 subjects the synergistic effects of SES and psychosocial risk factors such as
depression, hostility, and social isolation on biological and behavioral factors suspected
or known to contribute to atherogenesis. Subproject 2 evaluated the role of the central
nervous system serotonin function as a potential mediator of the clustering of
health-damaging psychosocial and biobehavioral characteristics in the same individuals and
low SES groups. Subproject 3, the Psychosocial Risk for Cardiovascular Disease in Youth
Project (PRCVDYP), used three ongoing general population studies of youth as a basis for
examining the development of psychosocial risk for cardiovascular disease. The investigators
hypothesized that low SES youth would exhibit, in addition to increased levels of the
psychosocial and behavioral risk factors under study, increased sympathetic nervous system
tone and reactivity to mental challenge, as well as decreased peripheral nervous system
tone. They also hypothesized that depression, social isolation, and harsh parenting will
interact with low SES to increase cardiovascular disease risk. Subproject 4 used a rat model
to investigate early experience, serotonin and adult function.
The study was renewed in FY 2004 and includes three subprojects. Subproject 1 will determine
the role of gene-environment interactions in the expression of psychosocial and
biobehavioral risk factors for cardiovascular disease. Variants will be identified in
candidate genes and chromosomal loci that are associated with the endophenotypes of
hostility, personality, other psychosocial risk factors, health behaviors, and the following
responses to rest and stress -- cardiovascular and neuroendocrine function, platelet
activation and serotonin transporter function, circulatory inflammatory markers and the
tendency of all of these characteristics to cluster in the same individuals and low
socioeconomic groups. A total of 400 probands (half African American, half Caucasian, half
women) and at least one sibling for each proband will be recruited for a total of 800 to
1200 subjects. Subproject 2 will explore in 400 subjects the genetics of glucose metabolism,
hostility, and cardiovascular disease risk factors. Subproject 3 will examine the genetics,
hostility and biology of stress in daily life in 400 probands and one sibling for every
proband.
;
Observational Model: Family-Based, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|